[Ingredient Spotlight] Azelaic Acid — What the Trials Show, and What the Buzz Adds

[Ingredient Spotlight] Azelaic Acid — What the Trials Show, and What the Buzz Adds

① Overview

Azelaic acid is a dicarboxylic acid used in dermatology for years. According to DermNet, it works in several ways: it reduces acne-associated bacteria such as C. acnes, it slows the overgrowth of cells that can clog pores, it scavenges free radicals, and it inhibits tyrosinase, an enzyme involved in pigment production. DermNet also notes that it does not cause antibiotic resistance and does not make skin sun-sensitive.

It comes in two very different settings. Prescription products are typically 15% gel (approved in the US for rosacea) or 20% cream (used for acne in several countries). Over-the-counter serums are commonly around 10%.

 

② Why It’s Trending

Trend trackers put azelaic acid near the top of 2026. One search-data site ranks it #2 among 50 skincare trends, with about 368,000 monthly searches as of August 2026 and 83% year-over-year growth. A social-listening vendor counts roughly 300,000 TikTok mentions over the past 12 months, mostly about pairing it with retinoids. Some K-beauty trend forecasts list it as well.

Two caveats. Both vendors are commercial and do not describe their methods, so these numbers are indicators, not verified measurements. And the same social-listening page shows Google searches down 5% over the most recent four weeks, labeling the trend “steady.” Popularity is not evidence, so the next section looks at the research.

 

③ Skin Benefits (With Evidence)

Almost everything below comes from human trials of prescription-strength creams and gels used on diagnosed conditions. None of the studies we reviewed tested sheet masks or everyday cosmetic serums.

Acne. A 2020 Cochrane review pooled 49 randomized trials (3,880 people) of six topical treatments. For azelaic acid, it “probably” works less well than benzoyl peroxide on self-rated improvement (one study, 351 people, moderate certainty) and about the same as tretinoin (one study, 289 people, moderate certainty). Versus clindamycin there may be little or no difference (one study, 229 people, low certainty), and versus adapalene the evidence is too weak to judge (55 people, very low certainty). Of the 49 trials, 26 had a high risk of bias in at least one area, and nine reported pharmaceutical support. The authors call for larger head-to-head trials.

Rosacea. A 2006 systematic review of randomized trials (five studies, 873 people) found that four showed significantly fewer inflammatory lesions and less redness than vehicle. None showed improvement in visible blood vessels. Missing data prevented a meta-analysis. A separate 15-week double-blind trial of 251 people found the 15% gel reduced lesions and redness more than 0.75% metronidazole gel, with more stinging. The version we could access was a single-site subset, and its sponsor was not stated. These trials are old, and larger modern ones would be welcome.

Melasma (dark patches). Evidence here is thinner. A 2023 trial of 50 women (10 weeks, single-blind) and a 2025 trial of 60 patients (4 months) both found 4% hydroquinone worked better or faster than 20% azelaic acid, while azelaic acid was gentler. Both are small and have reporting inconsistencies, and the 2025 trial assigned patients by alternating numbers rather than true randomization. Azelaic acid may suit people who cannot tolerate hydroquinone, but these trials do not show it is a replacement.

What has no evidence. We found no evidence for general “glowing” or anti-aging effects on healthy skin. We also did not locate a controlled trial of the popular azelaic acid and retinoid pairing; support for it is creator opinion. The trials we reviewed used 15–20%, and we found no controlled trial of 10% serums. That reflects our search, not proof that none exists.

 

④ Cautions & Formulation Tips

Mild irritation is the most common issue, and stinging was higher with the gel in the rosacea comparison. DermNet notes that lightening of skin (hypopigmentation) may be more noticeable in darker skin tones, that asthma worsening has been reported, and that people sensitive to ingredients such as propylene glycol should avoid some formulas. Stop and seek advice for severe redness, scaling, itching or burning.

Patience matters: DermNet gives about four weeks for early acne improvement, up to 12 weeks for rosacea, and roughly six months for the maximum acne effect. Dermatologists quoted in a consumer article suggest patch testing, applying it later in the routine, and avoiding stacking it with BHAs, which may increase dryness. Sunscreen still matters, because UV can undo pigment progress.

On pregnancy, dermatologists quoted in that article describe it as generally considered safe, but DermNet does not address it. Ask a doctor first. If you use a retinoid, add one new active at a time so you can tell what irritates your skin.


⑤ From Pureface

Trends move quickly, and evidence moves slowly. That is why this series separates what trials have shown from what feeds repeat. This post is educational and is not a statement about the formulas of any Pureface product. If you have rosacea, persistent acne, or stubborn dark patches, a dermatologist can tell you which strength fits your skin. For everyone else, the basics hold: introduce one new step at a time, be patient, and wear sunscreen daily.

0 comments

Leave a comment